Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

被引:54
作者
Figarella-Branger, Dominique [1 ,2 ]
Mokhtari, Karima [3 ,4 ,5 ]
Dehais, Caroline [6 ]
Jouvet, Anne [7 ]
Uro-Coste, Emmanuelle [8 ,9 ]
Colin, Carole [2 ]
Carpentier, Catherine [4 ,5 ]
Forest, Fabien [10 ]
Maurage, Claude-Alain [11 ]
Vignaud, Jean-Michel [12 ]
Polivka, Marc [10 ,13 ]
Lechapt-Zalcman, Emmanuelle [14 ,15 ]
Eimer, Sandrine [16 ,17 ]
Viennet, Gabriel [18 ]
Quintin-Roue, Isabelle [19 ]
Aubriot-Lorton, Marie-Helene [20 ]
Diebold, Marie-Daniele [21 ]
Loussouarn, Delphine [22 ]
Lacroix, Catherine [23 ]
Rigau, Valerie [24 ]
Laquerriere, Annie [25 ]
Vandenbos, Fanny [26 ]
Michalak, Sophie [27 ]
Sevestre, Henri [28 ]
Peoch, Michel
Labrousse, Francois [29 ]
Christov, Christo [30 ]
Kemeny, Jean-Louis [31 ]
Chenard, Marie-Pierre [32 ]
Chiforeanu, Danchristian [33 ]
Ducray, Francois [34 ,35 ]
Idbaih, Ahmed [3 ,4 ,5 ]
机构
[1] Hop La Timone, APHM, Serv Anat Pathol & Neuropathol, Marseille, France
[2] Aix Marseille Univ, INSERM, CRO2 UMR S 911, Marseille, France
[3] Grp Hosp Pitie Salpetriere, AP HP, Serv Neuropathol Raymond Escourolle, F-75634 Paris, France
[4] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, UMRS 975, Paris, France
[5] Inserm U975, Paris, France
[6] Grp Hosp Pitie Salpetriere, AP HP, Serv Neurol Mazarin 2, F-75634 Paris, France
[7] Ctr Pathol & Neuropathol Est, Bron, France
[8] Hop Rangueil, CHU Toulouse, Serv Anat Pathol & Histol Cytol, Toulouse, France
[9] Univ Toulouse, Inserm U1037, Ctr Rech Cancerol Toulouse, Toulouse, France
[10] Hop Nord St Etienne, CHU St Etienne, Serv Anat & Cytol Pathol, St Etienne, France
[11] CHU Lille, Serv Anat Pathol, F-59037 Lille, France
[12] Hop Cent, CHU Nancy, Anat Pathol Lab, Nancy, France
[13] Hop Lariboisiere, AP HP, Serv Anat & Cytol Pathol, F-75475 Paris, France
[14] Hop Cote Nacre, CHU Caen, Serv Anat Pathol, Caen, France
[15] CNRS, CERVOxy, GIP CYCERON, UMR ISTCT 6301, Caen, France
[16] Hop Pellegrin, CHU Bordeaux, Serv Pathol Neuropathol, F-33076 Bordeaux, France
[17] Univ Bordeaux Segalen, EA2406, Bordeaux, France
[18] Hop Jean Minjoz, CHU Besancon, Serv Anat & Cytol Pathol, F-25030 Besancon, France
[19] Hop Cavale Blanche, CHU Brest, Serv Anat Pathol, Brest, France
[20] CHU Dijon, Serv Anat & Cytol Pathol, Dijon, France
[21] Hop Robert Debre, CHU Reims, Lab Anat & Cytol Pathol, Reims, France
[22] Hop Laennec, CHU Nantes, Serv Anat Pathol B, Nantes, France
[23] Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, Le Kremlin Bicetre, France
[24] Hop Gui de Chaulliac, CHU Montpellier, Lab Anat & Cytol Pathol, Montpellier, France
[25] Hop Charles Nicolle, CHU Rouen, Pathol Lab, Rouen, France
[26] Hop Louis Pasteur, CHU Nice, Lab Anat & Cytol Pathol, F-06002 Nice, France
[27] CHU Angers, Dept Pathol Cellulaire & Tissulaire, Angers, France
[28] Hop Nord Amiens, CHU Amiens, Serv Anat & Cytol Pathol, Amiens, France
[29] Hop Dupuytren, CHU Limoges, Serv Anat Pathol, Limoges, France
[30] Hop Henri Mondor, AP HP, Serv Histol Embryol, F-94010 Creteil, France
[31] Hop Gabriel Montpied, CHU Clermont Ferrand, Serv Anat & Cytol Pathol, Clermont Ferrand, France
[32] Hop Hautepierre, CHU Strasbourg, Serv Anat Pathol, Strasbourg, France
[33] Hop Pontchaillou, CHU Rennes, Serv Anat & Cytol Pathol, Rennes, France
[34] Hop Pierre Wertheimer, Hosp Civils Lyon, Serv Neurooncol, Bron, France
[35] CNRS UMR5292, INSERM U1028, Bron, France
关键词
anaplastic oligodendrogliomas; 1p/19q codeletion; mitoses; microvascular proliferation; necrosis; IDH2; MUTATIONS; 19Q DELETION; 1P; TEMOZOLOMIDE; TUMORS; DISTINCT; GLIOMAS; IMPACT; TRIAL;
D O I
10.1093/neuonc/nou047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The aim of this study was to correlate histological features and molecular characteristics in anaplastic oligodendrogliomas (AOs). Methods. The histological characteristics of 203 AO patients, enrolled in the French national network POLA, were analyzed. The genomic profiles of 191 cases were studied using genomic arrays. IDH mutational status was assessed by immunohistochemistry and direct sequencing. Results. 1p/19q codeletion was present in 79% of cases and was associated with alpha-internexin expression (P < 10(-4)), IDH1/2 mutation (P < 10(-4)), chromosome 4 loss (P < 10(-3)), and better overall survival (P < 10(-4)). Based on mitotic index, microvascular proliferation (MVP), and necrosis, 3 groups of 1p/19q codeleted AOs were identified: (group 1) AO with more than 5 mitoses per 10-HPF, no MVP, and no necrosis; (group 2) AO with MVP and no necrosis; and (group 3) AO with MVP and necrosis. Compared with group 1, groups 2 and 3 AOs had a higher mean Ki-67 proliferation index and a higher rate of 9p and 9q losses. Compared with group 2, group 3 AOs had a higher number of chromosomal alterations including chromosome 4 loss. In the subgroup of 157 1p/19q codeleted AOs, chromosomal instability was associated with shorter progression-free survival (P = .024) and shorter overall survival (P = .023). Conclusions. The present study shows that oligodendrogliomas with classic histological features remain a molecularly heterogeneous entity and should be stratified according to 1p/19q status because of its major prognostic relevance. Moreover, 1p/19q codeleted AOs are also heterogeneous. Interestingly, mitotic index, MVP, and necrosis help to classify them into 3 groups associated with distinct genomic alterations.
引用
收藏
页码:1244 / 1254
页数:11
相关论文
共 26 条
[1]  
Bigner S H, 1999, Neuro Oncol, V1, P52, DOI 10.1093/neuonc/1.1.52
[2]   Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].
Cairncross, Gregory ;
Wang, Meihua ;
Shaw, Edward ;
Jenkins, Robert ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperriere, Normand ;
Curran, Walter ;
Mehta, Minesh .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343
[3]   Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression [J].
Coulibaly, Bema ;
Nanni, Isabelle ;
Quilichini, Benoit ;
Gaudart, Jean ;
Metellus, Philippe ;
Fina, Frederic ;
Boucard, Celine ;
Chinot, Olivier ;
Ouafik, L'Houcine ;
Figarella-Branger, Dominique .
HUMAN PATHOLOGY, 2010, 41 (06) :815-823
[4]   DNA Fragmentation Simulation Method (FSM) and Fragment Size Matching Improve aCGH Performance of FFPE Tissues [J].
Craig, Justin M. ;
Vena, Natalie ;
Ramkissoon, Shakti ;
Idbaih, Ahmed ;
Fouse, Shaun D. ;
Ozek, Memet ;
Sav, Aydin ;
Hill, D. Ashley ;
Margraf, Linda R. ;
Eberhart, Charles G. ;
Kieran, Mark W. ;
Norden, Andrew D. ;
Wen, Patrick Y. ;
Loda, Massimo ;
Santagata, Sandro ;
Ligon, Keith L. ;
Ligon, Azra H. .
PLOS ONE, 2012, 7 (06)
[5]   Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading [J].
Giannini, C ;
Scheithauer, BW ;
Weaver, AL ;
Burger, PC ;
Kros, JM ;
Mork, S ;
Graeber, MB ;
Bauserman, S ;
Buckner, JC ;
Burton, J ;
Riepe, R ;
Tazelaar, HD ;
Nascimento, AG ;
Crotty, T ;
Keeney, GL ;
Pernicone, P ;
Altermatt, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (03) :248-262
[6]   Anaplastic oligodendroglial tumors: Refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402 [J].
Giannini, Caterina ;
Burger, Peter C. ;
Berkey, Brian A. ;
Cairncross, J. Gregory ;
Jenkins, Robert B. ;
Mehta, Minesh ;
Curran, Walter J. ;
Aldape, Ken .
BRAIN PATHOLOGY, 2008, 18 (03) :360-369
[7]   Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas [J].
Godraind, C ;
Rousseau, E ;
Ruchoux, MM ;
Scaravilli, F ;
Vikkula, M .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (05) :462-471
[8]   Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss [J].
Griffin, Constance A. ;
Burger, Peter ;
Morsberger, Laura ;
Yonescu, Raluca ;
Swierczynski, Sharon ;
Weingart, Jon D. ;
Murphy, Kathleen M. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (10) :988-994
[9]   IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas [J].
Houillier, C. ;
Wang, X. ;
Kaloshi, G. ;
Mokhtari, K. ;
Guillevin, R. ;
Laffaire, J. ;
Paris, S. ;
Boisselier, B. ;
Idbaih, A. ;
Laigle-Donadey, F. ;
Hoang-Xuan, K. ;
Sanson, M. ;
Delattre, J. -Y. .
NEUROLOGY, 2010, 75 (17) :1560-1566
[10]   SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas [J].
Idbaih, Ahmed ;
Ducray, Francois ;
Dehais, Caroline ;
Courdy, Celia ;
Carpentier, Catherine ;
de Bernard, Simon ;
Uro-Coste, Emmanuelle ;
Mokhtari, Karima ;
Jouvet, Anne ;
Honnorat, Jerome ;
Chinot, Olivier ;
Ramirez, Carole ;
Beauchesne, Patrick ;
Benouaich-Amiel, Alexandra ;
Godard, Joel ;
Eimer, Sandrine ;
Parker, Fabrice ;
Lechapt-Zalcman, Emmanuelle ;
Colin, Philippe ;
Loussouarn, Delphine ;
Faillot, Thierry ;
Phong Dam-Hieu ;
Elouadhani-Hamdi, Selma ;
Bauchet, Luc ;
Langlois, Olivier ;
Le Guerinel, Caroline ;
Fontaine, Denys ;
Vauleon, Elodie ;
Menei, Philippe ;
Fotso, Marie Janette Motsuo ;
Desenclos, Christine ;
Verelle, Pierre ;
Ghiringhelli, Franc Ois ;
Noel, Georges ;
Labrousse, Francois ;
Carpentier, Antoine ;
Dhermain, Frederic ;
Delattre, Jean-Yves ;
Figarella-Branger, Dominique .
PLOS ONE, 2012, 7 (10)